diazoxide vs raloxifene
Side-by-side comparison of diazoxide and raloxifene. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Highly protein-bound drugs include diazepam, diazoxide, and lidocaine. 7.3 Other Highly Protein-Bound Drugs Raloxifene hydrochloride should be used with caution with certain other highly protein-bound drugs such as diazepam, diazoxide, and lidocaine.
Recommendation: Use this combination with caution. Your healthcare provider may need to monitor your response to these medications more frequently.
Proglycem
Evista
VYKAT XR is a medicine used to treat excessive hunger in people with Prader-Willi syndrome. It helps to control their appetite.
Raloxifene (Evista) is a medicine that can help treat and prevent bone loss (osteoporosis) in women after menopause. It can also lower the chance of getting a certain type of breast cancer.
VYKAT XR treats hyperphagia (excessive hunger) in people aged 4 years and older who have Prader-Willi syndrome (PWS). PWS is a genetic disorder that can cause constant hunger. This medicine helps manage the strong urge to overeat.
This medicine is used to treat and prevent osteoporosis in women after menopause. It can also lower the risk of invasive breast cancer in women after menopause who have osteoporosis or are at high risk of getting it. This medicine is not for treating breast cancer, lowering the risk of breast cancer coming back, or lowering the risk of non-invasive breast cancer.
VYKAT XR contains diazoxide choline. It is thought to work by affecting how insulin is released in the body. This helps to reduce hunger.
Raloxifene belongs to a class of drugs called Selective Estrogen Receptor Modulators (SERMs). It works like estrogen in some parts of the body, such as bones, which helps to prevent bone loss. But it blocks estrogen's effects in other parts of the body, like the breast, which can help prevent certain types of breast cancer.
- • Increased hair growth
- • Swelling
- • High blood sugar
- • Rash
- • Fever
- • Hot flashes
- • Leg cramps
- • Swelling in your legs or feet
- • Flu-like symptoms
- • Joint pain
- Low blood sugar 97
- High blood sugar 45
- The medicine is not working for a condition it's not approved for 38
- The medicine is interacting with another medicine 30
- Swelling in the arms or legs 25
- Feeling tired 143
- Joint pain 109
- Diarrhea 109
- Falling down 107
- Feeling sick to your stomach 106
VYKAT XR can cause high blood sugar, sometimes leading to a serious condition called diabetic ketoacidosis. Watch for signs like excessive thirst, frequent urination, and increased appetite with weight loss. This medicine can also cause fluid overload. Tell your doctor if you notice swelling or other signs of fluid retention.
Raloxifene can increase your risk of blood clots in your veins (deep vein thrombosis) and lungs (pulmonary embolism). If you have had blood clots in the past, you should not take this medicine. Raloxifene can also increase the risk of death from stroke in women who have heart disease or are at risk for heart problems. Talk to your doctor about the risks and benefits of taking raloxifene if you are at risk for stroke.
It is not known if VYKAT XR can harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. It is also not known if VYKAT XR passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
You should not take this medicine if you are pregnant or could become pregnant. It may harm your unborn baby. Do not use this medicine if you are breastfeeding.
Also Compare, Nearby Drugs
Compare raloxifene with
How to Read This diazoxide vs raloxifene Comparison
diazoxide is classified in the Potassium Channel Opener (Hyperinsulinism) drug class, while raloxifene sits within the Selective Estrogen Receptor Modulator (SERM) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, diazoxide has 235 submissions while raloxifene has 574. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to these drugs compete for the same binding spots on proteins in your bloodstream. this competition can change how much of each drug is active in your body at one time.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between diazoxide and raloxifene - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.